chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within 10 minutes of administration, patient reported feeling poorly. Reported lightheadedness and chills.  EMS was present and assisted. On exam, elevated BP 180/118. SpO2 98% on RA. Patient was given juice and water and assisted to a quiet area to lay down. EMS stayed with her and continued to monitor.  After 30 minutes patient reported feeling better and left vaccine area with her friend.  She was feeling better by her report in the afternoon.  Received a call at 9:30pm that evening.  Reported same symptoms she had initially.  She was advised to go to the ER for further evaluation but she declined.  She took benadryl 25mg and rested.  Reported feeling better the next day. Fatigue and mild headache.  I saw her in the office for a BP recheck on 4/12.  BP 120/70. She reported feeling much better with just some mild residual fatigue.
Breakthrough case admission after 3 vaccines Moderna 2/5/21 Lot# 011M20A;  Moderna 3/5/21 Lot# 030A21A;  Moderna 11/4/21 Lot# 033F21A
This spontaneous report was received from a registered pharmacist regarding a patient of unknown age and unknown gender. The patient's medical history or concurrent conditions were not provided. On 13-APR-2016, the patient was vaccinated with an expired dose of ZOSTAVAX (lot number reported as 1603AA, expiration date 13-JAN-2013) route and anatomical location were not provided). Concomitant medications were not provided. No adverse effect was reported. A product quality complaint (PQC) was reported and filed. Additional information has been requested.
chills, shakiness followed by feeling very warm, sweating and sweaty, Extreme fatigue, body aches, joint pain. Injection site pain. Muscle pain. Nausea--did throw up twice. General feeling unwell. The fatigue has gone on for two weeks now. Starting to get better.
given Hiberix reconstituted with sterile water; given Hiberix reconstituted with sterile water; This case was reported by a nurse via call center representative and described the occurrence of wrong solution used in drug reconstitution in a patient who received Hib (Hiberix) (batch number 594CF, expiry date 13th July 2022) for prophylaxis.   On an unknown date, the patient received Hiberix. On an unknown date, unknown after receiving Hiberix, the patient experienced wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. On an unknown date, the outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The age at vaccination was not reported. A nurse reported that, it was possible that, the patient was given Hiberix that might have been incorrectly reconstituted with sterile water instead of saline, which led to wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. Healthcare professional did not have specific patient information or dates administered at the time of report.  The healthcare professional stated that, the specific lot was administered over a range of a couple of months.  The reporter consented to follow up. This was 1 of 9 linked cases reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR024234:Same reporter US-GLAXOSMITHKLINE-US2022AMR024236:Same reporter US-GLAXOSMITHKLINE-US2022022662:Same reporter US-GLAXOSMITHKLINE-US2022AMR024235:Same reporter US-GLAXOSMITHKLINE-US2022AMR024238:Same reporter US-GLAXOSMITHKLINE-US2022AMR024239:Same reporter US-GLAXOSMITHKLINE-US2022AMR024240:Same reporter US-GLAXOSMITHKLINE-US2022AMR024241:Same reporter
Systemic: Dizziness / Lightheadness-Mild, Systemic: Nausea-Mild, Additional Details: patient was dizzy after getting the shot and called to let me know that her nbody feels on fire she has still dizziness and nausea. no pain after the shot. Gve her a drink and some crackers asked her if she wants me to call 911 she refused
ON 29 MAR 07 I WAS GIVEN THE ANTHRAX SHOT, AND THE NEXT DAY I HAD A REACTION.  THE AREA WHERE THE SHOT WAS GIVEN HAD SWELLING AND REDNESS.  IT WAS THERE FOR OVER 2WKS WITH THE LUMP IN THE AREA.  I VISITED THE CLINIC THE NEXT DAY AND PROVIDED A PHOTO OF THE AFFECTED AREA.
At Approximately 1040, patient (Age 35,) received her 2nd dose of Pfizer vaccine (Lot# 6200 Exp. 06/2021). At approximately 1055, EMT was alerted by patient that she felt her tongue somewhat swollen and itchiness in the back of tongue, patient was sitting in observation chair at this time, A&Ox4. At approximately 1100, pt was moved to zero gravity chair, water was given, pt remained A&Ox4 and pink in color. Pt reported allergy to Penicillin- reaction Hives and also has seasonal allergies, with no past history of anaphylaxis. At approximately 1112, RN Lead spoke with patient and EMT about how patient is feeling, patient declined to have EMS called, patient was offered Benadryl, patient agreed and took Benadryl 25mg in 10ml Oral Solution. Vital signs at 1117: HR 74, RR 14, BP 130/90, Vital Signs at 1123 HR 70, RR 14, BP 128/90. At 1125, Patient claims symptoms not worsening. At 1128, tongue did not swell up more than initial complaint. At 1128, Pt stated she ?felt better? and left the facility, Pt A&Ox4, pink in color, ambulating with steady gait, driving herself in her vehicle. Pt verbalized understanding to call her doctor or 911 if she felt anything worsening.
My symptoms were sore throat, swollen throat, nasal congestion, coughing, loss of appetite, fever (temperature unknown).
pt recvd vax; devel fine rash on back on 9dec,lasted 3 days,12dec devel t 101 relieved by apap;fever lasted x 3 days;13dec devel rhinorrhea;was irritable but consolable; emesed 2 x;exp loss of appetite;if sxs persist,see MD again;
Patient completed COVID-19 Vaccine with Pfizer-Biontech vaccine on 3/29/21 and 4/19/21. Seen in primary care 7/22/21 for sinus drainage and fever beginning on 7/21/21. Given Rx for azithromycin and tested for COVID-- positive on 7/22. Received casirivimab/imdevimab infusion on 7/29/21. Presented to ED with worsening resp symptoms on 7/30/21. Admitted for treatment to telemetry unit.
provider order the Meningococcal ACWY instead was given the Meningococcal B Vaccine
02/03/2021- 1ST DOSE MODERNA 03/03/2021 - 2ND DOSE MODERNA 08/13/2021- PT TESTED POSITIVE FOR COVID19 VIA PCR TEST. PT WAS ASYMPTOMACTIC AT TIME OF TESTING.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose01/14/21 2nd dose02/04/21 Diagnosed covid positive:09/13/21 Symptom onset:09/09/21 Exposure:work Symptoms:fatigue, sore throat,runny nose
Patient received the second shingrix shot and her first pneumonia shot of prevnar 13  She got her shingrix was perfectly fine  Did her pneumonia in right arm. She felt lightheaded within 1 minute and had to sit down. Said she had never felt dizzy like this before and was very hot. We asked if she needed anything she said no. Her husband standing next to her watching her and I as the pharmacist checked in every 2-3 minutes to see if she was ok. Suddenly she dropped her head and went unconscious and had labored breathing. Called ems immediately. Patient was unresponsive for 30 seconds and she came back. Had epi and Benadryl ready to give within 1 minute. However she was recovering from what seemed like syncope. Ems arrived within 5 minutes. They took her BP and her  diastolic was 66ish (she had measured before in our automated machine and it was around 76ish). So they said she had syncope most likely and they monitored her and she refused to go on ambulance and went home as she?s a retired nurse and knew how she was feeling. She had some orange juice while ems was here and we turned on the fan in front of her and that seemed to help her.
This case was reported by a healthcare professional and described the occurrence of injection site redness in a 4-year-old female subject who was vaccinated with KINRIX (GlaxoSmithKline), varicella virus vaccine (non-gsk).  The subject's medical history included allergy to amoxicillin.  Concurrent vaccination included MMR II (non-gsk); Merck given on 15 June 2010.  Concurrent medications included Tuberculin PPD given on the left forearm on 15 June 2010.  On 15 June 2010 the subject received 1st dose of KINRIX (.5 ml, unknown route, left thigh), 2nd dose of varicella virus vaccine (Non-GSK) (unknown route, left thigh).  On 15 June 2010, less than one day after vaccination with KINRIX and Varicella virus vaccine (Non-GSK), the subject experienced injection site redness and injection site warmth.  The events occurred on her left thigh.  The subject was treated with BENADRYL.  At the time of reporting the events were unresolved.  The healthcare professional considered the events were possibly related to vaccination with KINRIX and Varicella virus vaccine (Non-GSK).
He received the booster dose and had pain in the lymph nodes for several days after receiving the vaccines.; He received the booster dose and had pain in the lymph nodes for several days after receiving the vaccines.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  An adult male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: Unknown. , Not available/provided to reporter at the time of report completion), for Covid-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown. , Not available/provided to reporter at the time of report completion), for Covid-19 immunization. The following information was reported: IMMUNISATION (non-serious), outcome "unknown", LYMPH NODE PAIN (non-serious), outcome "recovered" and all described as "He received the booster dose and had pain in the lymph nodes for several days after receiving the vaccines.". It was unknown if therapeutic measures were taken as a result of lymph node pain.  The lot number for bnt162b2 was not provided and will be requested during follow up.
This 70 year old male patient was administered one dose of the H1N1 Vaccine on 22Dec2009. It is unknown if the patient had any previous allergy or reaction to the H1N1 vaccine. This patient was in for an office visit and reported that he began to experience a severe rash on 23Dec2009 and stated that it was very itchy and he couldn't sleep. The adverse drug reaction (ADR) did not abate after discontinuing the suspected drug. The patient was referred to dermatology and diagnosed with lichen planus probably secondary to vaccination with the H1N1 vaccine. Additional laboratory testing was required because of the ADR and was normal and there was no hematuria.  The patient was treated with topical steroids and antihistamine including  triamcinolone cream (TAC) and Atarax but the Atarax made him shaky.  The patient was also prescribed ultraviolet B light (UVB)  twice a week. The outcome of the events is unknown.
About three days post 2nd vaccine, my left upper arm/shoulder area started to experience only when I'd extend my arm or try working with my left arm overhead.  No redness or swelling.  It is now 8 days post injection and I am still experiencing the same pain only when my left arm is extended or raised overhead.   Feels more like a muscle tear than stiffness.
Congestion, sinus infection, and cough. Treated initially with Amoxicillin on 1/5/22.  Not improved on 1/14/22 so visited with Dr. via email and was asked to take a Covid-19 test. Also prescribed Benzonatate.
Shingles, including any and all of its sequelae; severe reaction to the medication Valacyclovir; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a 70-year-old male patient. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On 14-JUL-2016 (at the age of 70), the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose# and route not specified) for prophylaxis. As a result of his receipt of zoster vaccine live (ZOSTAVAX), on 19-JUL-2016, the patient was caused to suffered shingles, including any and all of its sequelae, including a severe reaction to the medication valacyclovir he was prescribed to treat his shingles. As a result of his receipt of zoster vaccine live (ZOSTAVAX), the patient was caused to suffer severe personal injuries, pain, suffering, and emotional distress, as well as to incur substantial economic damages. The outcome of the events was unknown. The reporter considered the events to be related to zoster vaccine live (ZOSTAVAX).
Systemic: None- Frige excursion-Mild, Additional Details: Fridge excursion 10/29/22 a few degrees too cold overnight for a few hours not detected until 1/9/2023
Information has been received from a medical assistant referring to an unspecified number of patients of unknown age and gender. The patients' medical history and concurrent conditions were not reported. Concomitant therapies included sterile diluent (manufacturer unknown). On 01-SEP-2017, the patients were vaccinated with improperly stored PROQUAD (dose, frequency and route were unknown, lot # M044720, expiration date: 07-MAY-2018, lot # N013863, expiration date: 31-OCT-2018) for prophylaxis. Administered vaccine experienced the temperature excursion of -14 Celsius degree to -10 Celsius degree (-14.2 Celsius degree) for 6 hours. There was no previous temperature excursion. Data logger was involved. No adverse effects reported. No product quality complaint (PQC) was involved. All telephone attempts on 10-OCT-2017 to obtain follow up information have been unsuccessful. Follow up information has been received from another reporter concerning a 4 year old patient. On 19-SEP-2017, the patient vaccinated with improperly stored PROQUAD (dose, frequency and route were unknown, lot # N013863, expiration date: 31-OCT-2018) for prophylaxis. This is one of several reports from the same reporter. Sender's Comments: US-009507513-1709USA002186: US-009507513-1709USA002098.
Dry heaves; overall feeling of unwell; no appetite; lack of bladder control; headache; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 11Oct2021 17:00 (Lot number: FF8841) at the age of 73 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "depression" (unspecified if ongoing); "heart disease" (unspecified if ongoing); "Hashimoto's thyroiditis" (unspecified if ongoing); "high BP" (unspecified if ongoing); "Known allergy: latex" (unspecified if ongoing); "Known allergy: cholesterol meds" (unspecified if ongoing); "Covid-19" (unspecified if ongoing), notes: If_covid_prior_vaccination: yes. The patient's concomitant medications were not reported. Past drug history included: Bactrim ds, reaction(s): "allergy"; Neosporin, reaction(s): "Allergy"; Erythromycin, reaction(s): "Allergy". Vaccination history included: Bnt162b2 (Second Dose, Brand=Pfizer, Lot number=EN6207 , vaccine location=Left arm, Administration Time: 02:15 PM), administration date: 11Apr2021, when the patient was 72 years old, for COVID-19 immunization; Bnt162b2 (First dose, Brand=Pfizer, Lot number=EW0151, Vaccine location=Left arm, Vaccine Administration Time: 02:00 PM), administration date: 18Mar2021, when the patient was 72 years old, for COVID-19 immunization. The following information was reported: RETCHING (non-serious) with onset 12Oct2021 02:00, outcome "recovering", described as "Dry heaves"; MALAISE (non-serious) with onset 12Oct2021 02:00, outcome "recovering", described as "overall feeling of unwell"; DECREASED APPETITE (non-serious) with onset 12Oct2021 02:00, outcome "recovering", described as "no appetite"; URINARY INCONTINENCE (non-serious) with onset 12Oct2021 02:00, outcome "recovering", described as "lack of bladder control"; HEADACHE (non-serious) with onset 12Oct2021 02:00, outcome "recovering", described as "headache". Therapeutic measures were not taken as a result of retching, malaise, decreased appetite, urinary incontinence, headache. No follow-up attempts are possible. No further information is expected.
Pt reports she developed hives and itching five days after receiving her third dose of Moderna. She has seen her doctor and dermatologist. She is using calamine lotion prn and benadryl every night at bedtime to treat symptoms.
Patient received FluMist vaccination on 5 Nov 07.  Patient was asymptomatic until 7-10 days later when developed malaise. Patient took 100mg acetaminophen q6h for 4 days then symptoms changed to fever, chills and productive cough treated with OTC items.  On 6 Dec 07 patient appeared for medical treatment after noticing hemorrhagic bullous lesion on his lips and oral mucosa on 5 Dec, and petechiae on legs on 4 Dec.  Labs showed platelet count of zero, which was confirmed.  Patient was diagnosed with suspected ITP with possible relation to vaccine and evacuated to medical center.  8/15/08 Reviewed medical reccords of 12/5/07-6/10/2008. FINAL DX: Idiopathic thrombocytopenia purpura assoc w/flumist vaccine. Records reveal patient experienced arthralgias, myalgias & fatigue approx 1 week s/p vaccination; HA, fever, chills & night sweats 10 days s/p vaccination; nasal congestion, post nasal drip, throat tickling, hacking cough w/SOB 2 weeks s/p vaccination; & dark spots on lower lip & legs, nosebleed, bleeding from lip lesion & productive bloody cough & extensive petechiae 1 month s/p vaccination.  Dx w/pneumonia intially but CBC revealed thrombocytopenia w/a platelet count of 0.  Admitted & tx w/steroids.  Transferred to higher level of care & tx w/platelet transfusion & IVIG.  Gradually improved & transferred to hospital on continued steroids.  Improved & d/c to home w/continued heme/onc f/u w/serial labs.
12-15 hours after the injection I woke up with moderate to severe body aches and fatigue. These two symptoms lasted about 12-18 hours.
Patient stated that redness started from the injection site and down. His entire upper arm is red and warm to touch. He also reported that he was extremely nauseated and couldn't perform his daily duties.
Red rash around injection site same day of shot & still 10 days later.  Still swollen lump on arm.
No additional AE; expired dose of PROQUAD was given; This spontaneous report was received from a medical assistant referring to a 4 years old patient of unknown gender. The patient concomitant medication, pertinent medical history and drug reactions and allergies were not provided.      On 18-FEB-2021, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (therapy type (rHA)) (strength and route were not provided; lot# was S023651 and expiration date was 26-JAN-2021), 0.5 ml for prophylaxis (expired product administered). No additional adverse event (AE) was reported. This vaccine did not experience a temperature excursion.
Information has been received from a nurse referring to an unspecified number of unspecified patients of unknown age and gender. Information about concurrent condition, drug reactions/allergies and medical history was unknown. Concomitant therapies included sterile diluent. From 07-JUL-2017 to 09-AUG-2017, the patients each was vaccinated with improperly stored doses of VARIVAX (dose and route unknown, lot # M009764 with expiry date 23-FEB-2018, N009768 with expiry date 24-MAR-2019, N012487 with expiry date 20-APR-2019 and M024681 with expiry date 18-MAY-2018) for prophylaxis. No adverse effect was reported. The vaccines were under the temperature range of -14 degree Celsius to -10 degree Celsius for 24 hours, -9 degree Celsius to 8 degree Celsius for 24 hours and 9 degree Celsius to 25 degree Celsius for 24 hours. There was no previous temperature excursion. A data digital logger was used. Sender's Comments: US-009507513-1709USA004451: US-009507513-1709USA004452.
I received the COVID-19 vaccine on Friday, February 12th, four days after my February 8th hip replacement surgery. On Saturday afternoon, about 24hr from the vaccine is the time I started feeling all side effects of the vaccine (Moderna). I had chills like I've never had before. Blankets did not help. I had to resort to an electric blanket before finding some relief. My temperature went up to 102.5. I was nauseous and I could not eat. We monitored my temperature between 7:00pm to 1:00 am. It started to decline and dropped to 99.5  by 1:00am.My fever started to decline and dropped to 99 by 1:00am It is now holding the normal range of 97.5 today. (2/14).
Bilateral sensorineural hearin loss; Decreased hearing; This initial spontaneous report was received from a lawyer regarding a case in litigation referring to a patient (pt) of unknown age and gender. The pt's pertinent medical history, concurrent conditions or concomitant medications were not reported. In or around 30-AUG-2017, the pt was vaccinated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dosage and route of administration were not provided) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). On an unspecified date, shortly after receiving zoster vaccine live (ZOSTAVAX), the pt suffered acute hearing loss bilaterally. Pt was diagnosed with bilateral sensorineural hearing loss (deafness neurosensory) and decreased hearing (hypoacusis). It was also specified that the pt suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. The events were considered to be related to zoster vaccine live (ZOSTAVAX) vaccination.  Upon internal review, deafness neurosensory was considered medically significant.